| Class/Generic | Brand | CYP 1A2 | 2C | 2D6 | 3A4 | Warnings | 
| SSRI |   |   |   |   |   |   | 
| Citalopram | Celexa |   |   | + (I) |   | Taper on  (D/C) | 
| Escitalopram | Lexapro |   |   | + (I) |   | 
| Fluoxetine | Prozac |   | ++ (I) | ++++ (I) | ++ (I) | 
| Fluvoxamine | Luvox | ++++ (I) | ++ (I) | 0/+ (I) | +++(I) | 
| Paroxetine | Paxil |   |   | +++ (S,I) |   | 
| Sertraline | Zoloft |   | ++ (I) | + (I) | + (I) | 
| SNRI |   |   |   |   |   |   | 
| Venlafaxine | Effexor |   |   | 0/+ (S)(I) |   | Mon. BP | 
| Desvenlafaxine | Pristiq |   |   |   |   | 
| Duloxetine | Cymbalta |   |   | ++ (I) |   | 
| Tricyclics Secondary Amines |   |   |   |   |   | 
| Desipramine | Norpramin |   |   |   |   | arrhythmias   Must taper on D/C | 
| Nortriptyline | Pamelor |   |   |   |   | 
| Miscellaneous |   |   |   |   |   |   | 
| Bupropion | Wellbutrin |   |   | + (I) |   |  | 
        
        | Term 
 
        | What are the alternative treatment options for MDD, and what are their warnings? |  | Definition 
 
        | 
| Class Generic | Brand | Warnings |  
| Serotonin Modulators |   |  
| Nefazodone | Serzone | Liver failure |  
| Trazodone | Desyrel |   |  
| TCA |   |   |  
| Amitriptyline | Elavil | Overdose Side effects |  
| Clomipramine | Anafranil |  
| Doxepin | Sinequan |  
| Imipramine | Tofranil |  
| MOA-inhibitors |   |   |  
| Phenelzine | Nardil | Orthostasis HTN crisis with foods  and medications |  
| Selegiline | Emsam |  
| Tranylcypromine | Parnate |  
| SNRI |   |   |  
| Milnacipran | Savella | Not FDA  approved MDD |  |  | 
        |  | 
        
        | Term 
 
        | What is the Acute phase of depression? |  | Definition 
 
        | - Active depression sx - Can last 6-10 weeks - Goal is remission by 20% decrease in sx |  | 
        |  | 
        
        | Term 
 
        | What is the continuation phase of depression? |  | Definition 
 
        | - Assumes remission and tries to prevent relapse within 6 months of remission.   - Typically lasts 4-5 months - Assumes remission.  Otherwise, it is still acute phase |  | 
        |  | 
        
        | Term 
 
        | What is the maintenance phase of depression? |  | Definition 
 
        | - Assumes remission - Goal is to prevent reoccurence - Typically lasts 1-3 years in duration   |  | 
        |  | 
        
        | Term 
 
        | For mild cases of depression in the acute phase, what treatment would you use? |  | Definition 
 
        | Typically just an antidepressant, just psychotherapy, or a combo if nothing else works |  | 
        |  | 
        
        | Term 
 
        | For moderate-severe cases of depression in the acute phase, what treatment would you use? |  | Definition 
 
        | - Antidepressant - Combination therapy - ECT   |  | 
        |  | 
        
        | Term 
 
        | For severe cases of depression in the acute phase, what treatment would you use? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are some important points regarding antidepressant selection? |  | Definition 
 
        | - Use a first-line - Comparable efficacy between classes based on STAR*D trial - Initial antidepressant should be low dose  (not necessarily lowest), and titrate up - Intial selection based on previous response of patient, medical and family history - Titration speed will depend on Age, Agent, Adverse effects, co-morbid conditions   Watching for response - Decrease of >50% on symptom scale seen within 2 weeks.  4-8 weeks for full effect.  Side-effects appear before therapeutic effect.  Improvement in Neurovegetative effects noticed first (Sleep, appetite, energy, irritability) |  | 
        |  | 
        
        | Term 
 
        | What is the treatment algorithm if there is no response in the acute phase? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the treatment algorithm if there is a partial response in the acute phase? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the treatment algorithm in the maintenance phase? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are some considerations when switching an antidepressant therapy? |  | Definition 
 
        | - Was the dose optimized or maximized? - How long did the patient have the optimal dose?  Should be for 6 weeks - Selection of another agent is same criteria as choosing the first - If switching to MAOI need washout period of 2-5 weeks (depending on Half-life) b/c of serotonin syndrome |  | 
        |  | 
        
        | Term 
 
        | What are the symptoms of serotonin syndrome? |  | Definition 
 
        | - Changes in mental status - Nausea - Diaphoresis - Agitation - Hypertension - Unresponsiveness - Seizures |  | 
        |  | 
        
        | Term 
 
        | What are some medications implicated in serotonin syndrome? |  | Definition 
 
        | - SSRI - SNRI - TCA - MAOI - Lithium - Not an all inclusive list |  | 
        |  | 
        
        | Term 
 
        | What are some medications to be used during Augmentation, which is used after a partial response when several agents have already been tried? |  | Definition 
 
        | - Lithium (mood stabilizer) - Stimulant - Methylphenidate - Amphetamine - Thyroid Hormone - Second Generation antipsychotic |  | 
        |  | 
        
        | Term 
 
        | What is special about geriatric patients who take antidepressants? |  | Definition 
 
        | - Longer time to see response (6-12 weeks) - Drug interactions with poly-pharmacy regimens - Concomittant disease states - Suicide risk |  | 
        |  | 
        
        | Term 
 
        | What is special about pediatric patients who take antidepressants? |  | Definition 
 
        | - FDA Black Box Warning - Increased risk of suicide - Fluoxetine is only FDA approved medication for MDD, requires close monitoring (they mean only one approved for pediatrics?!) - |  | 
        |  | 
        
        | Term 
 
        | What are the risk factors for suicide in pediatric and geriatric patients? |  | Definition 
 
        | - Prior attempt - Windowed/unmarried - Living alone - Lack of social support/family involvement - Unemployed - History of past psychiatric admissions - Substance abuse - Significant symptoms - Depressed - Hopeless - Family history of suicide - Anniversary of loss - Serious medical problem (AIDS?) - Refusal for help |  | 
        |  | 
        
        | Term 
 
        | What are some important factors to consider in pregnant/lactating patients in depression? |  | Definition 
 
        | - Complex decision process involved in how to treat - Risk vs. Benefit - Antidepressants not recognized to cause major birth defects - Treatment with SSRI in third trimester causes low birth weight and increased CNS symptoms - Bupropion is category B - Highest concentration in breast milk reported with Doxepin and Fluoxetine |  | 
        |  |